MediPharm Labs Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	10.58	11.69	17.98	24.15	34.11	19.91
Cash & Short-Term Investments	10.58	11.69	17.98	24.15	34.11	19.91
Cash Growth	-19.16%	-34.99%	-25.53%	-29.21%	71.30%	-48.45%
Accounts Receivable	7.72	7.51	5.87	12.88	16.92	29.65
Inventory	0.17	0.15	0.01	7.78	10.98	22.14
Other Current Assets	1.52	5.17	2.89	2.55	3.54	9.82
Total Current Assets	27.93	33.08	36.63	93.86	65.55	81.52
Net Property, Plant & Equipment	17.95	19.16	25.27	18.11	25.89	34.14
Other Intangible Assets	0.72	0.85	1.03	0.04	0.04	0.23
Other Long-Term Assets	-	0.64	1	-	0.88	2.34
Total Assets	46.6	53.73	63.94	65.5	92.36	118.23
Accounts Payable	8.01	7.86	6.75	7.12	6.21	14.79
Accrued Expenses	0.3	2.3	1.89	1.74	2.55	1.46
Short-Term Debt	0.42	0.34	2.23	0.6	0.11	7.7
Unearned Revenue	-	-	-	-	0	-
Other Current Liabilities	-	-	-	-	-	0.3
Total Current Liabilities	8.74	10.5	10.86	9.46	8.88	24.25
Long-Term Debt	-	0.05	0.07	0.03	0.1	11.06
Other Long-Term Liabilities	-	-	-	-	0.24	4.51
Total Long-Term Liabilities	-	0.05	0.07	0.03	0.34	15.57
Total Liabilities	8.74	10.55	10.93	9.49	9.22	39.82
Common Stock	201.64	201.21	200.24	191.26	190.55	138.51
Additional Paid-in Capital	24.95	29.56	29.53	28.4	21.91	14.85
Accumulated Other Comprehensive Income	-0.1	-0.16	-0.04	-	0.03	-0.4
Retained Earnings	-188.63	-187.43	-176.73	-163.65	-129.34	-74.54
Total Common Shareholders' Equity	37.86	43.18	53.01	56.01	83.15	78.41
Shareholders' Equity	37.86	43.18	53.01	56.01	83.15	78.41
Total Liabilities & Equity	46.6	53.73	63.94	65.5	92.36	118.23
Total Debt	0.42	0.39	2.3	0.63	0.22	18.76
Net Cash (Debt)	10.16	11.3	15.69	23.51	33.89	1.16
Net Cash Growth	-10.10%	-27.95%	-33.29%	-30.63%	2834.55%	-95.88%
Net Cash Per Share	0.02	0.03	0.04	0.09	0.14	0.01
Book Value	37.86	43.18	53.01	56.01	83.15	78.41
Book Value Per Share	0.09	0.11	0.15	0.20	0.33	0.57
Tangible Book Value	37.14	42.33	51.97	55.97	83.1	78.19
Tangible Book Value Per Share	0.09	0.10	0.14	0.20	0.33	0.56

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.